Answers are grounded in this paper and cite their sources.
A number of recent advances have been made in the clinical diagnosis and prognostication of multiple sclerosis patients. Future research will enable the development of more accurate biomarkers of disease categorization and prognosis, which will enable timely personalized treatment in individual multiple sclerosis patients.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: